Advertisement

21st International AIDS Conference (AIDS 2016)

Feature

How Can Community Engagement Support HIV Cure Research?

September 16, 2016

What is Good Participatory Practice (GPP)? Already the gold standard of HIV prevention research, these guidelines provide blueprints for engagement with a variety of stakeholders in research design and implementation. This approach can forge pathways to addressing some of the more tenacious misconceptions around HIV cure research. One of these, AVAC's Jessica Salzwedel explained, is the lack of information about the expected timeframe for a cure.

In a cross-sectional survey exploring beliefs and attitudes regarding HIV cure research among 400 U.S. adults living with HIV, as well as interviews with 36 stakeholders, 8% believed a cure already existed, and 60% believed a cure would happen in 10 years or fewer. Rumors to this effect continue to circulate throughout the community and are fueled by misguided media headlines attaching the word "cure" to a range of non-cure HIV developments.

Community engagement in HIV cure research, guided by GPP, can combat this misinformation by opening dialogue between research teams and stakeholders to facilitate education and accurately translate HIV cure research language. Benefits of a GPP approach extend beyond debunking misconceptions, to addressing practical concerns and assuaging fears among would-be trial participants.

Education and transparency are key goals in building trust within a research site and the community in which it is situated, Salzwedel says. It is also essential that all stakeholders connected with HIV cure research are aware that future populations, not current participants, will reap the direct benefits of early-phase HIV cure research.

With HIV cure research on the horizon, explore some of the other top ethical questions being asked in advance here.

Olivia G. Ford is a contributing editor for TheBody.com and TheBodyPRO.com.


Copyright © 2016 Remedy Health Media, LLC. All rights reserved.





This article was provided by TheBodyPRO.com. It is a part of the publication The 21st International AIDS Conference (AIDS 2016).
 


No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.